David Golden

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi request reprint Patterns of anaphylaxis: acute and late phase features of allergic reactions
    David B K Golden
    Johns Hopkins Allergy Center, Johns Hopkins University, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA
    Novartis Found Symp 257:101-10; discussion 110-5, 157-60, 276-85. 2004
  2. doi request reprint Long-term outcome after venom immunotherapy
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland 21224, USA
    Curr Opin Allergy Clin Immunol 10:337-41. 2010
  3. doi request reprint Venom immunotherapy reduces large local reactions to insect stings
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA
    J Allergy Clin Immunol 123:1371-5. 2009
  4. doi request reprint Dialyzed venom skin tests for identifying yellow jacket-allergic patients not detected using standard venom
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland 21224, USA
    Ann Allergy Asthma Immunol 102:47-50. 2009
  5. ncbi request reprint What is anaphylaxis?
    David Bk Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland 21224, USA
    Curr Opin Allergy Clin Immunol 7:331-6. 2007
  6. pmc Insect sting anaphylaxis
    David B K Golden
    Johns Hopkins University, 733 North Broadway, Baltimore, MD 21205, USA
    Immunol Allergy Clin North Am 27:261-72, vii. 2007
  7. ncbi request reprint Insect allergy in children
    David B K Golden
    Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Curr Opin Allergy Clin Immunol 6:289-93. 2006
  8. ncbi request reprint Clinical and entomological factors influence the outcome of sting challenge studies
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA
    J Allergy Clin Immunol 117:670-5. 2006
  9. ncbi request reprint Insect sting allergy and venom immunotherapy
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland 21224, USA
    Ann Allergy Asthma Immunol 96:S16-21. 2006
  10. ncbi request reprint Insect sting allergy and venom immunotherapy: a model and a mystery
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA
    J Allergy Clin Immunol 115:439-47; quiz 448. 2005

Research Grants

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Patterns of anaphylaxis: acute and late phase features of allergic reactions
    David B K Golden
    Johns Hopkins Allergy Center, Johns Hopkins University, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA
    Novartis Found Symp 257:101-10; discussion 110-5, 157-60, 276-85. 2004
    ..But they occurred in only 6% of anaphylaxis of mixed causes and are uncommon with insect stings. Late phase (biphasic) reactions rarely occur without initial hypotension or airway obstruction...
  2. doi request reprint Long-term outcome after venom immunotherapy
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland 21224, USA
    Curr Opin Allergy Clin Immunol 10:337-41. 2010
    ..This review will summarize the published evidence for current guidelines and recommendations, with emphasis on long-term outcomes...
  3. doi request reprint Venom immunotherapy reduces large local reactions to insect stings
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA
    J Allergy Clin Immunol 123:1371-5. 2009
    ..Venom immunotherapy is not recommended because of a low risk for future systemic reaction and unproven efficacy in preventing large local reactions...
  4. doi request reprint Dialyzed venom skin tests for identifying yellow jacket-allergic patients not detected using standard venom
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland 21224, USA
    Ann Allergy Asthma Immunol 102:47-50. 2009
    ..The chance of a nonspecific intradermal skin test response at venom concentrations greater than 1.0 microg/mL limits the diagnostic range and can interfere with the diagnosis of some affected patients...
  5. ncbi request reprint What is anaphylaxis?
    David Bk Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland 21224, USA
    Curr Opin Allergy Clin Immunol 7:331-6. 2007
    ..The possible components and steps in the process (proven and hypothetical) are reviewed with respect to their variation and regulation and their potential for therapeutic intervention...
  6. pmc Insect sting anaphylaxis
    David B K Golden
    Johns Hopkins University, 733 North Broadway, Baltimore, MD 21205, USA
    Immunol Allergy Clin North Am 27:261-72, vii. 2007
    ..Venom immunotherapy is 75% to 98% effective in preventing sting anaphylaxis. Most patients can discontinue treatment after 5 years, with very low residual risk of a severe sting reaction...
  7. ncbi request reprint Insect allergy in children
    David B K Golden
    Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Curr Opin Allergy Clin Immunol 6:289-93. 2006
    ..Some aspects of insect sting allergy are unique in children. This review will identify and update the published data that exist pertaining specifically to insect allergy in children...
  8. ncbi request reprint Clinical and entomological factors influence the outcome of sting challenge studies
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA
    J Allergy Clin Immunol 117:670-5. 2006
    ..The reported frequency of systemic reactions to challenge sting varies greatly...
  9. ncbi request reprint Insect sting allergy and venom immunotherapy
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland 21224, USA
    Ann Allergy Asthma Immunol 96:S16-21. 2006
    ..To review specific aspects of venom immunotherapy (VIT) in the context of allergen immunotherapy (AIT) in general...
  10. ncbi request reprint Insect sting allergy and venom immunotherapy: a model and a mystery
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA
    J Allergy Clin Immunol 115:439-47; quiz 448. 2005
    ..Some patients have a higher risk of relapse and should continue treatment for an extended period...
  11. ncbi request reprint Outcomes of allergy to insect stings in children, with and without venom immunotherapy
    David B K Golden
    Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA
    N Engl J Med 351:668-74. 2004
    ..We studied the outcome of allergic reactions to insect stings in childhood 10 to 20 years afterward in patients who had not received venom immunotherapy and in those who had been treated...
  12. ncbi request reprint Pearls and pitfalls of allergy diagnostic testing: report from the American College of Allergy, Asthma and Immunology/American Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force
    Linda Cox
    Department of Medicine, Nova Southeaster University Osteopathic College of Medicine, Davie, Florida 33334, USA
    Ann Allergy Asthma Immunol 101:580-92. 2008
    ....
  13. ncbi request reprint Stinging insect allergy
    David B K Golden
    Johns Hopkins University School of Medicine, Asthma and Allergy Center, Baltimore, Maryland 21224, USA
    Am Fam Physician 67:2541-6. 2003
    ..Venom immunotherapy is administered every four to eight weeks for at least five years. Immunotherapy may be needed indefinitely in patients at higher risk for recurrence of anaphylaxis after treatment is stopped...
  14. ncbi request reprint Expression of activation markers on basophils in a controlled model of anaphylaxis
    Laura M Gober
    Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    J Allergy Clin Immunol 119:1181-8. 2007
    ..Expression of activation markers on basophils has been useful in assessing sensitization in IgE-mediated diseases but has not been examined in vivo in anaphylaxis...
  15. ncbi request reprint Increased expression of osteopontin is associated with long-term bee venom immunotherapy
    Satoshi Konno
    Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA
    J Allergy Clin Immunol 115:1063-7. 2005
    ..Venom allergen immunotherapy (VIT) is proven to be highly effective for insect allergy, but the mechanisms and the biomarkers associated with clinical efficacy remain elusive...
  16. ncbi request reprint Level of osteopontin is increased after bee venom immunotherapy
    Satoshi Konno
    J Allergy Clin Immunol 115:1317-8. 2005
  17. ncbi request reprint Negative venom skin test results in patients with histories of systemic reaction to a sting
    David B K Golden
    Insect Allergy Committee, American Academy of Allergy, Asthma and Immunology, 611 E Wells Street, Milwaukee, WI 53202, USA
    J Allergy Clin Immunol 112:495-8. 2003
    ..We reviewed the current status of what is known about the management of individuals with a history of insect allergy but negative venom skin test results and suggested modifications of current working guidelines...
  18. ncbi request reprint Allergy diagnostic testing: an updated practice parameter
    I Leonard Bernstein
    University of Cincinnati College of Medicine, Ohio, USA
    Ann Allergy Asthma Immunol 100:S1-148. 2008
  19. ncbi request reprint Risk assessment in anaphylaxis: current and future approaches
    F Estelle R Simons
    Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Canada, and Department of Respiratory Medicine, Brighton General Hospital, Belfast, UK
    J Allergy Clin Immunol 120:S2-24. 2007
    ....
  20. ncbi request reprint Stinging insect hypersensitivity: a practice parameter update
    John E Moffitt
    Joint Council of Allergy, Asthma and Immunology, 50 N Brockway St, 3 3, Palatine, IL 60067, USA
    J Allergy Clin Immunol 114:869-86. 2004
  21. ncbi request reprint Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy
    Joanne N G Oude Elberink
    Department of Allergology, University Hospital Groningen, The Netherlands
    J Allergy Clin Immunol 109:162-70. 2002
    ..The effects of an anaphylactic reaction after a yellow jacket sting on health-related quality of life (HRQL) have not been studied and are thus unknown...

Research Grants2

  1. IN VITRO APPROACH TO PROBLEMS OF CLINICAL ALLERGY
    David Golden; Fiscal Year: 2005
    ..We need to continue to study these patients to develop the most useful clinical guidelines. ..